Hims & Hers Health stock price drops, insiders report share sales

LootboxPhobia · 2026-04-07T23:27:34+00:00

Hims & Hers Health Inc (NYSE:HIMS) stock price dropped 5.3% following Chief Financial Officer Oluyemi Okupe's filing to sell 240,560 shares. The stock sale plan follows the 10b5-1 rule and involves multiple transactions over the past few months, with significant cumulative gains. The company's stock has declined a total of 30.8% over the past year.

LootboxPhobia

2026-04-07 23:27:34

Abstract generation in progress

Investing.com – Hims & Hers Health Inc (NYSE:HIMS) shares fell 5.3% on Tuesday, after an insider filed to sell a large block of shares in the company.

The stock drop came as a Form 144 filing showed that the company’s Chief Financial Officer Oluyemi Okupe plans to sell 240,560 shares through Goldman Sachs, with a total market value of about $4.9 million. The proposed sale date is April 6, 2026.

The filing shows that the shares were acquired through various compensation arrangements, including stock options and restricted stock units between February 2022 and March 2026. The sale is being carried out under a 10b5-1 trading plan adopted on May 21, 2025.

According to the filing, Okupe has sold shares multiple times over the past three months, including trades on January 5, 2026, January 20, 2026, February 3, 2026, March 20, 2026, and April 6, 2026. The total proceeds from these sales ranged from about $20,000 to $151,000 per transaction.

As of the time of the filing, Hims & Hers Health had 219,561,143 shares outstanding. The company is headquartered in San Francisco, California. Its stock has recently dropped sharply, down 30.8% over the past year.

Under Rule 144 of the U.S. Securities Act of 1933, when insiders plan to sell restricted or control securities, they must file a Form 144. Such filings often draw investor attention because they may reflect insiders’ views on the company’s prospects, though sales carried out under a pre-arranged trading plan are typically seen as routine portfolio management.

This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.